Authors
Loading...
Preclinical study demonstrates quercitrin improves cardiac ejection fraction and suppresses fibrosis in mice following myocardial infarction, highlighting therapeutic metabolic reprogramming.
Liu et al. (2024) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: